Strong Hearts for New York: A Rural Heart Disease Prevention Study
Launched by CORNELL UNIVERSITY · Feb 16, 2017
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
There are notable cardiovascular disease (CVD) disparities among people living in rural settings, particularly medically underserved rural areas. Complex factors such as socioeconomic disadvantage, social and cultural dynamics, geographic distances/barriers, and limited access to healthcare, healthy foods, and/or physical activity opportunities contribute to the issue. The objective of Strong Hearts, Healthy Communities (SHHC) is to reduce rural CVD disparities through civic engagement and implementation of a community-based intervention in 11 underserved New York communities. SHHC builds u...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Body Mass Index (BMI) greater than or equal to 25
- • If BMI is less than 30, not currently physically active
- • Blood pressure is less than 160/100 mm Hg
- • Heart rate is between 60-100 bpm
- • English-speaking
- • Able and willing to obtain physician's approval to participate in intervention starting either in March 2017 or September 2017
- • Willing to participate in assessment activities
- • Willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017
- Exclusion Criteria:
- • BMI less than 25
- • If BMI is less than 30, currently physically active
- • Untreated hypertension
- • Heart rate lower than 60 or higher than 100 bpm
- • Non-English speaking
- • Not able or willing to obtain physician's approval to participate
- • Not interested or willing to participate in assessment activities
- • Not able or willing to make a firm commitment to participate in intervention starting either in Spring or Fall 2017
About Cornell University
Cornell University is a prestigious Ivy League institution renowned for its commitment to academic excellence and innovative research. As a clinical trial sponsor, Cornell leverages its interdisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve patient outcomes. The university fosters collaboration among leading researchers, clinicians, and students, aiming to translate scientific discoveries into effective therapies. Cornell's rigorous adherence to ethical standards and regulatory compliance ensures the integrity and safety of its clinical trials, contributing to the advancement of healthcare and the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clyde, New York, United States
Cobleskill, New York, United States
Cooperstown, New York, United States
Dolgeville, New York, United States
Hamilton, New York, United States
Hartwick, New York, United States
Herkimer, New York, United States
Ithaca, New York, United States
Ithaca, New York, United States
Milford, New York, United States
Morrisville, New York, United States
Newark, New York, United States
Sharon Springs, New York, United States
Patients applied
Trial Officials
Rebecca Seguin, PhD
Principal Investigator
Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials